Thierry Le Chevalier

Author

Also Known As

Ariane Dunant, Chevalier T.L., Chevalier, Thierry, D H Johnson, Didier Schwab, Le Chevalier, Thierry, T Chevalier, T Le Chevalier, T le Chevalier, T. Chevalier

362

Publications

23K

Citations

H-Index

118

Concepts

All Affiliations

Institut Gustave Roussy Inserm Medical University of Vienna Institute Mutualiste Montsouris Université Paris-Sud

About

Thierry Le Chevalier is an author at Institut Gustave Roussy specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	89	7.5K
2	Health Sciences	21	23	2.7K
3	Engineering	2	2	117
4	Natural Sciences	1	1	46
5	Nursing	1	1	35

Thierry Le Chevalier

135

Publications

17.7K

Citations

H-Index

Page 1

	Year	Citations
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti, Journal of Clinical Oncology	2008	2.6K
DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy Ken A. Olaussen, Ariane Dunant, Pierre Fouret, New England Journal of Medicine	2006	1.7K
Malignant effusions and immunogenic tumour-derived exosomes Fabrice André, Noël E.C. Schartz, Mojgan Movassagh, The Lancet ExosomesPathologyExtracellular MicrovesiclesMedicineMalignant Disease	2002	934
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. Thierry Le Chevalier, D. Brisgand, Jean‐Yves Douillard, Journal of Clinical Oncology	1994	823
Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 Patients Thierry Le Chevalier, R. Arriagada, Élisabeth Quoix, JNCI Journal of the National Cancer Institute Adaptive RadiotherapySurgical OncologyFirst AnalysisRadiation TherapyMedicine	1991	804
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC Benjamin Besse, Mélinda Charrier, Valérie Lapierre, OncoImmunology ImmunologyImmunotherapeuticsImmunotherapyFirst Line ChemotherapyTumor Immunology	2015	754
Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and Implications Fabrice André, Dominique Grunenwald, Jean‐Pierre Pignon, Journal of Clinical Oncology	2000	486
Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer R. Arriagada, Ariane Dunant, Jean‐Pierre Pignon, Journal of Clinical Oncology	2009	392
ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer Luc Friboulet, Ken A. Olaussen, Jean‐Pierre Pignon, New England Journal of Medicine	2013	362
Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer Élisabeth Brambilla, Gwénaël Le Teuff, Sophie Marguet, Journal of Clinical Oncology	2016	354

Page 1